Stay Ahead of Compliance with Monthly Citation Updates


In your State Survey window and need a snapshot of your risks?

Survey Preparedness Report

One Time Fee
$79
  • Last 12 months of citation data in one tailored report
  • Pinpoint the tags driving penalties in facilities like yours
  • Jump to regulations and pathways used by surveyors
  • Access to your report within 2 hours of purchase
  • Easily share it with your team - no registration needed
Get Your Report Now →

Monthly citation updates straight to your inbox for ongoing preparation?

Monthly Citation Reports

$18.90 per month
  • Latest citation updates delivered monthly to your email
  • Citations organized by compliance areas
  • Shared automatically with your team, by area
  • Customizable for your state(s) of interest
  • Direct links to CMS documentation relevant parts
Learn more →

Save Hours of Work with AI-Powered Plan of Correction Writer


One-Time Fee

$49 per Plan of Correction
Volume discounts available – save up to 20%
  • Quickly search for approved POC from other facilities
  • Instant access
  • Intuitive interface
  • No recurring fees
  • Save hours of work
F0756
D

Failure to Implement Pharmacy Recommendation for Psychoactive Medication

Fremont, Michigan Survey Completed on 04-10-2025

Penalty

No penalty information released
tooltip icon
The penalty, as released by CMS, applies to the entire inspection this citation is part of, covering all citations and f-tags issued, not just this specific f-tag. For the complete original report, please refer to the 'Details' section.

Summary

A deficiency occurred when the facility failed to act upon a pharmacy recommendation regarding the administration of a psychoactive medication for one resident. The resident, who was admitted with non-traumatic brain dysfunction and had moderate cognitive impairment as indicated by a BIMS score of 10 out of 15, was prescribed Lorazepam as needed without a stop date. The pharmacy conducted a drug regimen review and recommended that as-needed non-antipsychotic psychotropic drugs be limited to 14 days unless the prescriber documented the specific condition being treated, the rationale for the extended use, and the duration of the order. The physician accepted this recommendation in writing. Despite the physician's acceptance, the order for Lorazepam remained active beyond the recommended 14-day period without a documented stop date, specific condition, or rationale for continued use. Review of the electronic medical record confirmed that the pharmacy's recommendation was not implemented, and the resident continued to receive Lorazepam past the recommended stop date. The deficiency was acknowledged by the Director of Nursing after being informed of the oversight.

An unhandled error has occurred. Reload 🗙